What does a reactive hepatitis C antibody test indicate?

What Does a Reactive Hepatitis C Antibody Test Mean?

A reactive hepatitis C antibody test indicates one of three possibilities: current (active) HCV infection, past resolved infection, or rarely a false positive result—you cannot determine which without confirmatory HCV RNA testing. 1, 2

Immediate Next Step

Order HCV RNA testing immediately on the same sample (reflex testing) to determine if the person has active infection. 1 This is critical because:

• A positive antibody test alone does NOT confirm active infection
• Approximately 15-45% of people clear HCV spontaneously, leaving antibodies behind
• False positives occur, particularly in low-risk populations with elevated immunoglobulins

Interpreting the Results

If HCV RNA is Detected (Positive):

• This confirms current, active HCV infection requiring linkage to care and treatment 1, 2
• Most cases represent chronic infection (>6 months duration)
• The patient is infectious and needs antiviral therapy evaluation
• Counsel on transmission prevention and refer to hepatology/infectious disease

If HCV RNA is Not Detected (Negative):

• This indicates either past resolved infection OR a false positive antibody result 1, 2
• Inform the patient they do NOT have current HCV infection
• They are NOT infectious to others
• They are NOT protected from reinfection—can acquire HCV again 1

Important Clinical Caveats

The "Window Period" Problem

For persons exposed to HCV within the past 6 months, a negative HCV RNA doesn't definitively rule out infection because:

• They may be in the early seroconversion window
• Repeat HCV RNA or antibody testing at 6+ months post-exposure 1, 2

Immunocompromised Patients

Consider direct HCV RNA testing in immunocompromised individuals who may have:

• Delayed seroconversion
• Failed antibody response despite active infection 1

Signal-to-Cutoff (S/Co) Ratios Matter

While not always reported, the antibody signal strength provides useful information 3, 4:

• Very low S/Co ratios (1.0-2.5): High likelihood of false positive—only 5.7% represent true infection
• High S/Co ratios (>4.65): Strong predictor of true infection with >95% positive predictive value
• Low ratios often occur with elevated gamma globulins or autoimmune conditions 5

The Critical Importance of Reflex Testing

Single-visit sample collection with automatic reflex to HCV RNA testing is mandatory. 1, 6 Here's why:

• Historically, one-third of patients with reactive antibodies never complete RNA testing 6
• This represents a massive gap in the care continuum
• Requiring return visits for confirmatory testing is a major barrier
• Reflex testing rates have improved from 21.9% (2018) to 82.2% (2024) with guideline emphasis 7

Operational Approach:

1. Collect blood sample for HCV antibody testing
2. If reactive, the same sample automatically reflexes to HCV RNA without requiring another blood draw 1, 2
3. This eliminates the need for patient callback and second venipuncture

Common Pitfalls to Avoid

1. Never tell a patient they "have hepatitis C" based on antibody alone—you must confirm with RNA testing
2. Don't assume antibody-positive/RNA-negative means false positive—it likely represents resolved infection in high-risk populations
3. Don't forget reinfection risk—antibody-positive patients who cleared infection can get reinfected and need periodic RNA testing if ongoing risk 1
4. Don't order standalone antibody tests—always use reflex testing protocols 6

Special Populations Requiring RNA Testing

Order HCV RNA directly (not antibody) for:

• Persons at risk for reinfection after previous clearance (antibody will remain positive) 1
• Recent exposure within 6 months (may be antibody-negative)
• Immunocompromised patients (may not mount antibody response)
• Suspected acute hepatitis C with clinical symptoms

Bottom Line for Clinical Practice

A reactive HCV antibody is just the first step—it tells you the person has been exposed to HCV at some point but provides zero information about current infection status. The RNA test is what determines if treatment is needed, if the patient is infectious, and whether specialist referral is required. The 2020 AASLD-IDSA guidelines make clear: reflex RNA testing on all reactive antibodies is the standard of care. 1